Follow-The-Filings

Security · featured owners

CTNM Contineum Therapeutics Inc.

Health Care CL A Equity among managers we track

CTNM (Contineum Therapeutics Inc.) 13F ownership among featured managers we track. Figures are as-filed 13F, not free float.

No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.

SEC filings

Recent issuer filings from EDGAR · 12 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 8.01,9.01
8-K 2.02,9.01
10-Q
8-K 7.01,9.01
8-K 5.07
8-K 2.02,9.01
10-Q
8-K 7.01,8.01,9.01
DEFA14A
8-K 2.02,8.01,9.01
10-K
424B5

Insider forms

Form 3 / 4 / 5 from EDGAR · 15 rows shown

Filed Form Detail Links
4 Period Sep 8, 2026
4 Period Aug 3, 2026
4 Period Jul 8, 2026
4 Period Jul 8, 2026
4 Period Jun 30, 2026
4 Period Jun 30, 2026 · 2 forms
4 Period Jun 26, 2026 · 7 forms
4 Period Jun 1, 2026
4 Period May 1, 2026
4 Period Apr 6, 2026
4 Period Mar 2, 2026 · 2 forms
4 Period Feb 24, 2026 · 2 forms
4 Period Feb 19, 2026
4 Period Feb 11, 2026 · 2 forms
4 Period Feb 3, 2026

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2024 FY2025
Revenue $0.00
Net income -$42.26M -$59.98M

Balance sheet

Metric FY2024 FY2025
Total current assets $206.39M $267.92M
Total non-current assets * $6.46M $8.72M
Total assets $212.85M $276.64M
Total current liabilities $9.97M $9.74M
Total non-current liabilities * $4.81M $5.91M
Total equity $198.07M $260.99M

Cash flow

Metric FY2024 FY2025
Cash from operations -$32.84M -$55.31M
Cash from investing -$69.74M -$3.71M
Cash from financing $109M $112.68M
Net change in cash $6.42M $53.66M

ownership over time

filing count by report period · click a bar for that quarter’s holders